Post-treatment levels of α-fetoprotein predict long-term hepatocellular carcinoma development after sustained virological response in patients with hepatitis C-Reference-Cited by-同舟云学术

Post-treatment levels of α-fetoprotein predict long-term hepatocellular carcinoma development after sustained virological response in patients with hepatitis C

Published:2016-12-19 Issue:10 Volume:47 Page:1021-1031
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Tada Toshifumi¹,Kumada Takashi¹,Toyoda Hidenori¹,Kiriyama Seiki¹,Tanikawa Makoto¹,Hisanaga Yasuhiro¹,Kanamori Akira¹,Kitabatake Shusuke¹,Yama Tsuyoki¹,Tanaka Junko²

Affiliation:

1. Department of Gastroenterology and Hepatology; Ogaki Municipal Hospital; Ogaki Japan

2. Department of Epidemiology, Infectious Disease Control, and Prevention; Hiroshima University Institute of Biomedical and Health Sciences; Hiroshima Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12839/fullpdf

Reference36 articles.

1. Natural history of hepatitis C;Westbrook;J Hepatol,2014

2. Epidemiology of hepatocellular carcinoma in Japan;Umemura;J Gastroenterol,2009

3. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-α therapy;Marcellin;Ann Intern Med,1997

4. Long-term follow-up of chronic hepatitis C patients with sustained virological response to α-interferon;Reichard;J Hepatol,1999

5. Effect of interferon therapy on the natural history of hepatitis C virus-related cirrhosis and hepatocellular carcinoma;Poynard;Clin Liver Dis,1999

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lysyl oxidase-like 2 as a predictor of hepatocellular carcinoma in patients with hepatitis C virus after sustained virological response;Scientific Reports;2024-05-13

2. VFMAP predicted hepatocellular carcinoma development in patients with chronic hepatitis C who were treated with direct-acting antiviral and achieved sustained virologic response;Journal of Medical Ultrasonics;2023-12-26

3. FIB‑4 index and serum α‑fetoprotein are useful predictors of hepatocellular carcinoma occurrence in hepatitis B patients with nucleos(t)ide analogs therapy;Experimental and Therapeutic Medicine;2023-08-01

4. Characteristics of hepatocellular carcinoma in patients with hepatitis C virus who received direct‐acting antiviral therapy and achieved sustained virological response: The impact of a hepatologist on surveillance;JGH Open;2022-06-06

5. Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C who achieved a sustained virological response through direct‐acting antiviral agents among the working population in Japan;JGH Open;2022-05-18